AleciaCurleneNeroMD
Pediatric Hematology & Oncology • Dallas, TXPediatric Coagulation Disorder Hematology
Assistant Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School
Are you Dr. Nero?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 77 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-648-4180Fax+1 214-645-2836
Summary
- Dr. Alecia Nero, MD is a pediatric hematologist/oncologist in Dallas, Texas. She is currently licensed to practice medicine in Texas and Ohio. She is affiliated with University of Texas Southwestern Medical Center, Children's Medical Center Dallas, and William P. Clements, Jr. University Hospital.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2011- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine/Pediatrics, 2004 - 2008
University of Texas Southwestern Medical SchoolClass of 2004
Certifications & Licensure
TX State Medical License 2011 - 2026
OH State Medical License 2004 - 2011- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Losartan to Reverse Sickle Nephropathy Start of enrollment: 2012 Feb 01
Publications & Presentations
PubMed
- How do we manage hyperhemolysis syndrome.Brian D Adkins, Samer Z Kaylani, Alecia Nero, Ibrahim F Ibrahim, Yu-Min Shen
Transfusion. 2024-10-01 - COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network Study.Alan R Anderson, John J Strouse, Deepa Manwani, Amanda M Brandow, Elliott Vichinsky
Blood Advances. 2024-09-10 - 2 citationsRiociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trial.Mark T Gladwin, Victor R Gordeuk, Payal C Desai, Caterina Minniti, Enrico M Novelli
The Lancet. Haematology. 2024-05-01
Press Mentions
Spreading A Message of Hope, Child Living with Sickle Cell Anemia Shares Her StoryJune 11th, 2019- How Doctors Are Pressuring Sickle Cell Patients into Unwanted SterilizationsMay 22nd, 2024
